The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy

Medical Oncology

Volumn 31, Issue 12, 2014, Pages 1-4

  Rybka, Justyna ^a   Butrym, Aleksandra ^a   Wróbel, Tomasz ^a   Jaźwiec, Bożena ^a   Stefanko, Ewa ^a   Dobrzyńska, Olga ^a   Poręba, Rafał ^a   Kuliczkowski, Kazimierz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute leukemia; Bacterial infection; Sepsis; Toll like receptors

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYTARABINE; MESSENGER RNA; QUINOLINE DERIVATIVE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BONE MARROW; BONE MARROW BIOPSY; CANCER PATIENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; GENE EXPRESSION; HUMAN; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MYCOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEPSIS; ADOLESCENT; BACTEREMIA; COMPLICATION; CONTROLLED CLINICAL TRIAL; FUNGEMIA; GENETICS; LEUKEMIA, MYELOID, ACUTE; METABOLISM; MIDDLE AGED; STATISTICAL MODEL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; FEBRILE NEUTROPENIA; FEMALE; FUNGEMIA; HUMANS; INDUCTION CHEMOTHERAPY; LEUKEMIA, MYELOID, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; SEPSIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84919918334     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0319-7     Document Type: Article

References (17)

1. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med. 2006;84:712–25.
2. Banerjee A, Gerondakis S. Coordinating TLR-activated signaling pathways in cells of the immune system. Immunol Cell Biol. 2007;85:420–4.
3. Tsujimoto H, Ono S, Efron PA, Scumpia PO, Moldawer LL, Mochizuki H. Role of Toll-like receptors in the development of sepsis. Shock. 2008;29:315–21.
4. Stone R. Search for sepsis drugs goes on despite past failures. Science. 1994;1994(264):365–7.
5. Armstrong L, Medford AR, Hunter KJ, Uppington KM, Millar AB. Differential expression of Toll-like receptors (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol. 2004;136:312–9.
6. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;2011(34):637–50.
7. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. Host innate immune receptors and beyond: making sense of microbal infection. Cell Host Microbe. 2008;3:352–63.
8. Salomao R, Brunialti MK, Rapozo MM, Baggio-Zappia GL, Galanos C, Freudenberg M. Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock. 2012;38:227–42.
9. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–50.
10. Słotwiński R, Słotwińska SM, Bałan BJ, Kędziora S. Toll-like receptor signaling pathway in sepsis. Centr Eur J Immunol. 2009;34:124–8.
11. Salomao R, Martins PS, Brunialti MK, Fernandes ML, Martos LS, Mendes ME, et al. TLR signaling pathway in patients with sepsis. Shock. 2008;30:73–7.
12. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol. 2002;169:4697–701.
13. Cowan AJ, Altemeier WA, Johnston C, Gernsheimer T, Becker PS. Management of acute myeloid leukemia in the intensive care setting. J Intensive Care Med. 2014 [Epub ahead of print].
14. Holmes CL, Russel JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest. 2003;124:1103–15.
15. Arcaroli J, Fessler MB, Abraham E. Genetic polymorphisms and sepsis. Shock. 2005;24:300–12.
16. Arbour NC, Lorenz E, Schutte BC, et al. TLR-4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000;25:187–91.
17. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med. 2002;162:1028–32.